Ruihua Xu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer (NCT05163483) | Ruihua Xu | 2022-07-01 |
Track Ruihua Xu automatically
Every clearance here is in the API, with alerts when new ones post.